Contribution of activated interleukin receptors in trigeminal ganglion neurons to hyperalgesia via satellite glial interleukin-1beta paracrine mechanism.
The present study investigated whether under in vivo conditions, inflammation alters the excitability of nociceptive Adelta-trigeminal ganglion (TRG) neurons innervating the facial skin via a cytokine paracrine mechanism. We used extracellular electrophysiological recording with multibarrel-electrodes in this study, and complete Freund's adjuvant (CFA) was injected into the rat facial skin. The threshold for escape from mechanical stimulation applied to the whisker pad area in inflamed rats (2 days after CFA injection) was significantly lower than that in control rats. A total of 45 Adelta-nociceptive-TRG neurons responding to electrical stimulation of the whisker pad were recorded in pentobarbital-anesthetized rats. The number of Adelta-TRG neurons with spontaneous firings and their firing rate in inflamed rats were significantly larger than those in control rats. The firing rates of the Adelta-TRG neuronal spontaneous activity were current-dependently decreased by local iontophoretic application of an interleukin I receptor type I antagonist (IL-1ra) in inflamed rats, but not in controls, and current-dependently increased by iontophoretic application of interleukin 1beta (IL-1beta) in both control and inflamed rats. IL-1ra also inhibited Adelta-TRG neuron activity evoked by mechanical stimulation in the inflamed rats. The mechanical threshold of nociceptive-TRG neurons in inflamed rats was significantly lower than that in control rats, but was not significantly different between control and inflamed rats after application of an IL-1ra. These results suggested that inflammation modulates the excitability of nociceptive Adelta-TRG neurons innervating the facial skin via IL-1beta paracrine action within trigeminal ganglia. Such an IL-1beta release could be important in determining trigeminal inflammatory hyperalgesia.
Takeda
Mamoru
M
Department of Physiology, School of Life Dentistry at Tokyo, Nippon Dental University, 1-9-20, Fujimi-cho, Chiyoda-ku, Tokyo 102-8159, Japan. Electronic address: m-takeda@tokyo.ndu.ac.jp.
Takahashi
Masayuki
M
Department of Physiology, School of Life Dentistry at Tokyo, Nippon Dental University, 1-9-20, Fujimi-cho, Chiyoda-ku, Tokyo 102-8159, Japan.
Matsumoto
Shigeji
S
Department of Physiology, School of Life Dentistry at Tokyo, Nippon Dental University, 1-9-20, Fujimi-cho, Chiyoda-ku, Tokyo 102-8159, Japan.
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D004566:Electrodes; D004594:Electrophysiology / Q000295:instrumentation / Q000379:methods; D004924:Escape Reaction / Q000187:drug effects; D005145:Face / Q000294:innervation; D005620:Freund's Adjuvant; D006930:Hyperalgesia / Q000473:pathology / Q000503:physiopathology*; D007249:Inflammation / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000494:pharmacology; D053583:Interleukin-1beta / Q000502:physiology*; D008297:Male; D009457:Neuroglia / Q000166:cytology / Q000502:physiology*; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D017288:Pain Threshold / Q000187:drug effects; D019899:Paracrine Communication / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D018123:Receptors, Interleukin / Q000502:physiology; D012867:Skin / Q000294:innervation; D012668:Trigeminal Ganglion / Q000473:pathology / Q000503:physiopathology*; D014738:Vibrissae / Q000294:innervation
D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta; D018123:Receptors, Interleukin; D005620:Freund's Adjuvant